Q3 2025 Earnings Call October 29, 2025 4:30 PM EDTCompany ParticipantsChristopher Lewis - Vice President of Investor ...

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

A man with neurofibromas who didn't know he's been clinically diagnosed with NF1, learns he harbors a deeply intronic, likely ...

In the study, researchers molecularly screened nearly 2,000 cancer patients and matched 14 percent into a study arm.

For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...

EINPresswire/ -- "Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors Next-Generation Sequencing (NGS) In Precision ...

Get the latest on CMS Energy's Q3 2025 earnings: robust growth, $25B investment pipeline, and raised guidance.

Overview of Epigenetics MarketThe global Epigenetics Market is valued at USD 2.56 Billion in 2024 and is projected to reach a value of USD 9.11 Billion by 2035 at a CAGR (Compound Annual Growth Rate) ...

Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

Explore Generect’s real-time data pipeline. Learn how 400M contacts power instant lead discovery and seamless outreach campaigns.

DelveInsight's“ Retinitis Pigmentosa Pipeline Insight 2025 ” report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in the Retinitis Pigmentosa pipeline landscape. It covers ...